tetradecanoylphorbol acetate has been researched along with Brain Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pan, CF; Xiong, XX; Zheng, YY; Zhu, SM | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and Brain Diseases
Article | Year |
---|---|
Propofol inhibits aquaporin 4 expression through a protein kinase C-dependent pathway in an astrocyte model of cerebral ischemia/reoxygenation.
Topics: Animals; Animals, Newborn; Aquaporin 4; Astrocytes; Brain Diseases; Brain Edema; Cell Hypoxia; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Activators; Glucose; L-Lactate Dehydrogenase; Neocortex; Neuroprotective Agents; Oxygen; Propofol; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors | 2009 |